BGI News More
- BGI Genomics Announces Pricing of Initial Public Offering
- BGI Launches the Latest Desktop Sequencer BGISEQ-50
- International Science Community Welcomes China National GeneBank Opening
- BGI and Clearbridge BioMedics Partner to Develop China CTC Liquid Biopsy Market towards Precision Medicine
- The international Sc2.0 Project is on track to build the world’s first synthetic yeast genome
- Avian-specific conserved genomic elements play important regulatory roles in the macroevolution of avian-specific features
- The Evolution of Chronic Lymphocytic Leukemia Revealed
- BGI involved in publication of the first seahorse genome in Nature
- Leading Health Organizations in Canada and China Teaming up to Accelerate Precision Medicine
- World’s largest genomic organisation to collaborate with leading Queensland researchers
- Ranomics Partners with BGI to Classify Variants of Unknown Significance
- BGI and UW collaborate on precision medicine development
- Chinese innovation : BGI’s code for success
- Prof. Huanming Yang to Receive Membership from Royal Danish Academy of Sciences and Letters
- UW, Chinese genomics group forge new partnership to advance biomedical research
- Mapping more genomes will create a healthcare 'big data revolution'
Tel: +86-755-36307212Email: email@example.com
BGI to Receive $1.5B in ‘Collaborative Funds’ Over 10 Years from China Development Bank
Publish Date: 2010-01-29
2010-01-12 By Julia Karow Source: Genomeweb
BGI, China’s largest genome center, said last week that under a collaborative agreement it signed with the China Development Bank last month, it will receive $1.5 billion in ’collaborative funds’ over the next 10 years.
The funding will "help BGI build research and application platforms for sustainable development in agriculture, bio-energy, personalized healthcare, and related fields," according to a statement from the institute.
Zhuo Li, vice president of international collaborations at BGI, told In Sequence by e-mail that the funding is a long-term loan and does not involve other parties besides the bank. BGI plans to use the money both to build infrastructure and to cover its running costs.
He said BGI will determine how much of the funding to use each year, depending on its strategic and development plans.
According to Li, BGI has in the past received funding from government agencies for buildings and facilities, as well as research grants. He said it will be hard to predict how much public funding the institute will receive going forward.
CDB is one of three so-called policy banks in the People’s Republic of China. According to CDB’s website, the bank supports "infrastructure development initiatives, basic industries, and pillar industries" in China and promotes "coordination in regional development and restructuring key industries."
In the past, the bank has supported several "national key projects," including the South-to-North Water Diversion, the 2008 Beijing Olympics, the 2010 Shanghai World Expo, and the Shougang Group relocation project.
BGI, which is headquartered in Shenzhen and has branches in other locations, changed its name from Beijing Genomics Institute two years ago, according to Li, to better reflect that it is no longer exclusively located in Beijing.
The institute has research centers in the US, Europe, and Hong Kong, as well as seven genome research centers in mainland China for scientific collaboration and sequencing services.